|
1
|
Nasim F, Sabath BF and Eapen GA: Lung
cancer. Med Clin North Am. 103:463–473. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao M and Chen W: Epidemiology of lung
cancer in China. Thorac Cancer. 10:3–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoy H, Lynch T and Beck M: Surgical
treatment of lung cancer. Crit Care Nurs Clin North Am. 31:303–313.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mao Y, Yang D, He J and Krasna MJ:
Epidemiology of lung cancer. Surg Oncol Clin N Am. 25:439–445.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cotzomi-Ortega I, Aguilar-Alonso P,
Reyes-Leyva J and Maycotte P: Autophagy and its role in protein
secretion: Implications for cancer therapy. Mediators Inflamm.
2018:42315912018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Levy JMM, Towers CG and Thorburn A:
Targeting autophagy in cancer. Nat Rev Cancer. 17:528–542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schenk RL, Strasser A and Dewson G: BCL-2:
Long and winding path from discovery to therapeutic target. Biochem
Biophys Res Commun. 482:459–469. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rahman MA, Bishayee K, Habib K, Sadra A
and Huh SO: 18α-Glycyrrhetinic acid lethality for neuroblastoma
cells via de-regulating the Beclin-1/Bcl-2 complex and inducing
apoptosis. Biochem Pharmacol. 117:97–112. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song S, Wang B, Gu S, Li X and Sun S:
Expression of Beclin 1 and Bcl-2 in pancreatic neoplasms and its
effect on pancreatic ductal adenocarcinoma prognosis. Oncol Lett.
14:7849–7861. 2017.PubMed/NCBI
|
|
11
|
Jiang LC, Huang SY, Zhang DS, Zhang SH, Li
WG, Zheng PH and Chen ZW: Expression of beclin 1 in primary
salivary adenoid cystic carcinoma and its relation to Bcl-2 and p53
and prognosis. Braz J Med Biol Res. 47:252–258. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baspinar S, Bircan S, Orhan H, Kapucuoglu
N and Bozkurt KK: The relation of Beclin 1 and Bcl-2 expressions in
high grade prostatic intraepithelial neoplasia and prostate
adenocarcinoma: A tissue microarray study. Pathol Res Pract.
210:412–418. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (Eighth) edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu HD and Qin ZH: Beclin 1, Bcl-2 and
autophagy. Adv Exp Med Biol. 1206:109–126. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guadagno E, Borrelli G, Pignatiello S,
Donato A, Presta I, Arcidiacono B, Malara N, Solari D, Somma T,
Cappabianca P, et al: Anti-apoptotic and anti-oxidant proteins in
glioblastomas: Immunohistochemical expression of Beclin and DJ-1
and its correlation with prognosis. Int J Mol Sci. 20:40662019.
View Article : Google Scholar
|
|
16
|
Sun H, Yu J, Wen Z, Wang M and Chen W:
Decreased expression of Beclin-1 in patients with hepatocellular
carcinoma. J BUON. 24:634–641. 2019.PubMed/NCBI
|
|
17
|
Chen L, Liu Y, Zhang Q, Zhang M, Han X, Li
Q, Xie T, Wu Q and Sui X: p53/PCDH17/Beclin-1 proteins as
prognostic predictors for urinary bladder cancer. J Cancer.
10:6207–6216. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Wang X, Wang G, Li Z, Wang J,
Huang L, Qin Z, Yuan X, Cheng Z, Zhang S, et al: Integrating
multiple omics data for the discovery of potential Beclin-1
interactions in breast cancer. Mol Biosyst. 13:991–999. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Z, Ghoorun RA, Fan X, Wu P, Bai Y, Li
J, Chen H, Wang L and Wang J: High expression of Beclin-1 predicts
favorable prognosis for patients with colorectal cancer. Clin Res
Hepatol Gastroenterol. 39:98–106. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng T, Li D, He Z, Feng S and Zhao S:
Prognostic and clinicopathological significance of Beclin-1 in
non-small-cell lung cancer: A meta-analysis. Onco Targets Ther.
11:4167–4175. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qiu DM, Wang GL, Chen L, Xu YY, He S, Cao
XL, Qin J, Zhou JM, Zhang YX and E Q: The expression of Beclin-1,
an autophagic gene, in hepatocellular carcinoma associated with
clinical pathological and prognostic significance. BMC Cancer.
14:3272014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han Y, Xue XF, Shen HG, Guo XB, Wang X,
Yuan B, Guo XP, Kuang YT, Zhi QM and Zhao H: Prognostic
significance of Beclin-1 expression in colorectal cancer: A
meta-analysis. Asian Pac J Cancer Prev. 15:4583–4587. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qiu XG, Chen YD, Yuan J, Zhang N, Lei T,
Liu J and Yang M: Functional BCL-2 rs2279115 promoter noncoding
variant contributes to glioma predisposition, especially in males.
DNA Cell Biol. 38:85–90. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chi XX, Zhang T, Chu XL, Zhen JL and Zhang
DJ: The regulatory effect of Genistein on granulosa cell in ovary
of rat with PCOS through Bcl-2 and Bax signaling pathways. J Vet
Med Sci. 80:1348–1355. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Cai H, Huang H, Long Z, Shi Y and
Wang Y: The prognostic significance of apoptosis-related biological
markers in Chinese gastric cancer patients. PLoS One. 6:e296702011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Q, Li S, Cheng P, Deng M, He X, Wang
Z, Yang CH, Zhao XY and Huang J: High expression of anti-apoptotic
protein Bcl-2 is a good prognostic factor in colorectal cancer:
Result of a meta-analysis. World J Gastroenterol. 23:5018–5033.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Callagy GM, Webbe MJ, Pharoah PD and
Caldas C: Meta-analysis confirms BCL2 is an independent prognostic
marker in breast cancer. BMC Cancer. 8:1532008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
D'Arcy MS: Cell death: A review of the
major forms of apoptosis, necrosis and autophagy. Cell Biol Int.
43:582–592. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu Y, Li W, Ren L, Yang C, Li D, Han X,
Sun Y, Lv C and Han F: Inhibition of autophagy enhanced cobalt
chloride-induced apoptosis in rat alveolar type II epithelial
cells. Mol Med Rep. 18:2124–2132. 2018.PubMed/NCBI
|
|
30
|
Won KY, Kim GY, Kim YW, Song JY and Lim
SJ: Clinicopathologic correlation of Beclin-1 and Bcl-2 expression
in human breast cancer. Hum Pathol. 41:107–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
